Octreotide Acetate
- Product NDC
- 25021-453
- 11-digit product format
- 250210453
- Labeler code
- 25021
- Product ID
- 25021-453_1070a999-cf03-4d2d-9389-9b43231cb38a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- octreotide acetate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA090834
- Marketing category
- ANDA
- Marketing start
- 2013-12-15
- Marketing end
- 0000-00-00
- Substance
- OCTREOTIDE ACETATE
- Active strength
- 500 ug/mL
- Pharmacologic classes
- Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-453-01 | 25021045301 | 10 VIAL in 1 CARTON (25021-453-01) > 1 mL in 1 VIAL | 10 vial | 2013-12-15 | 0000-00-00 | No | No | Current |